Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-12

Clinical Trial Update: Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating glutamatergic and GABAergic mediators of antidepressant response in major depression, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: Mclean Hospital | Conditions: MDD, Citalopram | Phase 4 | Status: COMPLETED | Results posted: 2017-09-12